Representative Lisa C. McClain (R-Michigan) recently sold shares of Avantor, Inc. NYSE: AVTR. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Avantor stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
- Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.
Avantor Price Performance
NYSE:AVTR traded up $0.07 during trading hours on Tuesday, hitting $13.28. The company's stock had a trading volume of 4,553,368 shares, compared to its average volume of 10,578,789. The stock has a fifty day simple moving average of $13.13 and a 200-day simple moving average of $14.34. The company has a market capitalization of $9.05 billion, a P/E ratio of 13.41, a PEG ratio of 1.50 and a beta of 0.96. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.98 and a quick ratio of 0.67. Avantor, Inc. has a twelve month low of $10.82 and a twelve month high of $27.83.
Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the business earned $0.25 earnings per share. The business's quarterly revenue was down 1.1% compared to the same quarter last year. On average, analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on AVTR. Wells Fargo & Company cut their price target on Avantor from $19.00 to $16.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Barclays reissued an "overweight" rating and set a $13.00 price target (down from $15.00) on shares of Avantor in a research note on Monday, August 4th. Raymond James Financial set a $14.00 price target on Avantor and gave the company an "outperform" rating in a research note on Monday, August 4th. Morgan Stanley cut their price target on Avantor from $15.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Monday, August 4th. Finally, Royal Bank Of Canada cut their price target on Avantor from $20.00 to $17.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, Avantor has a consensus rating of "Hold" and a consensus target price of $15.50.
Check Out Our Latest Stock Analysis on AVTR
Institutional Investors Weigh In On Avantor
A number of hedge funds have recently added to or reduced their stakes in the business. Thrivent Financial for Lutherans increased its holdings in Avantor by 1.1% in the second quarter. Thrivent Financial for Lutherans now owns 2,651,697 shares of the company's stock worth $35,692,000 after purchasing an additional 29,599 shares in the last quarter. FORA Capital LLC bought a new stake in Avantor in the second quarter worth approximately $789,000. Evergreen Capital Management LLC bought a new stake in Avantor in the second quarter worth approximately $179,000. Tower Research Capital LLC TRC increased its holdings in Avantor by 13.8% in the second quarter. Tower Research Capital LLC TRC now owns 20,001 shares of the company's stock worth $269,000 after purchasing an additional 2,421 shares in the last quarter. Finally, Corient Private Wealth LLC increased its holdings in Avantor by 10,725.4% in the second quarter. Corient Private Wealth LLC now owns 3,540,650 shares of the company's stock worth $47,657,000 after purchasing an additional 3,507,943 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Avantor news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.20% of the company's stock.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Avantor Company Profile
(
Get Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report